期刊
MOLECULES
卷 27, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/molecules27030948
关键词
stimuli-responsive; drug delivery; lung cancer
资金
- aboratory of Life Sciences and Biomedicine of Zhejiang Province, Westlake University
- National Natural Science Foundation [82073297]
- Hangzhou Major Science and Technology Project [20172016A01]
- Natural Science Foundation of Zhejiang Province [LY20H310005, LQ22H180009]
- Clinical Pharmacy of Hangzhou Medical Key Discipline [2021-21-16]
- Postdoctoral Research Foundation of China [2021M702876]
Lung cancer is the most commonly diagnosed cancer worldwide, and the development of smart carriers for drug delivery presents a promising strategy for therapy.
Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death worldwide. Numerous drugs have been developed to treat lung cancer patients in recent years, whereas most of these drugs have undesirable adverse effects due to nonspecific distribution in the body. To address this problem, stimuli-responsive drug delivery systems are imparted with unique characteristics and specifically deliver loaded drugs at lung cancer tissues on the basis of internal tumor microenvironment or external stimuli. This review summarized recent studies focusing on the smart carriers that could respond to light, ultrasound, pH, or enzyme, and provided a promising strategy for lung cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据